Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors.

PURPOSE Methylphenidate (MPH) ameliorates attention problems experienced by some cancer survivors in the short term, but its long-term efficacy is unproven. PATIENTS AND METHODS This study investigates the long-term effectiveness of maintenance doses of MPH in survivors of childhood brain tumors (n = 35) and acute lymphoblastic leukemia (n = 33) participating in a 12-month MPH trial. Measures of attention (Conners' Continuous Performance Test [CPT], Conners' Rating Scales [CRS]), academic abilities (Wechsler Individual Achievement Test [WIAT]), social skills (Social Skills Rating System [SSRS]), and behavioral problems (Child Behavior Checklist [CBCL]) were administered at premedication baseline and at the end of the MPH trial while on medication. A cancer control group composed of patients who were not administered MPH (brain tumor = 31 and acute lymphoblastic leukemia = 23) was assessed on the same measures 12 [corrected] months apart. RESULTS For the MPH group, repeated measures analysis of variance revealed significant improvement in performance on a measure of sustained attention (CPT indices, P < .05); parent, teacher, and self-report ratings of attention (CRS indices, P < .05), and parent ratings of social skills or behavioral problems (SSRS and CBCL indices; P < .05). In contrast, the cancer control group only showed improvement on parent ratings of attention (Conners' Parent Rating Scale indices; P < .05) and social skills (SSRS and CBCL indices; P < .05). There was no significant improvement on the academic measure (WIAT) in either group. CONCLUSION Attention and behavioral benefits of MPH for childhood cancer survivors are maintained across settings over the course of a year. Although academic gains were not identified, MPH may offer benefits in academic areas not assessed.

[1]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[2]  Jeffrey S. Bedwell,et al.  Continuous Performance Test , 2012 .

[3]  W. Reddick,et al.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial. , 2010, Journal of pediatric psychology.

[4]  H. Conklin,et al.  Side Effects of Methylphenidate in Childhood Cancer Survivors: A Randomized Placebo-Controlled Trial , 2009, Pediatrics.

[5]  H. Conklin,et al.  Growth effects of methylphenidate among childhood cancer survivors: A 12‐month case‐matched open‐label study , 2009, Pediatric blood & cancer.

[6]  Jeffrey Ditterline Social Skills Rating System , 2008 .

[7]  W. Reddick,et al.  Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. , 2007, Journal of pediatric psychology.

[8]  W. Reddick,et al.  Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Amar Gajjar,et al.  Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors , 2003, Cancer.

[10]  P. Weber,et al.  Methylphenidate treatment. , 2002, Pediatric neurology.

[11]  P. Maruff,et al.  Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory , 2001, Psychological Medicine.

[12]  W E Reddick,et al.  Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Moleski,et al.  Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. , 2000, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[14]  J. Kramer,et al.  Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. , 2000, Neuropsychology.

[15]  A R Jadad,et al.  The Treatment of Attention-Deficit Hyperactivity Disorder: An Annotated Bibliography and Critical Appraisal of Published Systematic Reviews and Metaanalyses , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  Ronald T. Brown,et al.  Stimulant medication for the child with attention-deficit/hyperactivity disorder. , 1999, Pediatric clinics of North America.

[17]  P. Maruff,et al.  Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children , 1999, Psychological Medicine.

[18]  P. Britton,et al.  Attentional ability among survivors of leukaemia , 1999, Archives of disease in childhood.

[19]  T. Fears,et al.  Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. , 1994, JAMA.

[20]  R. Noll,et al.  Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique. , 1994, Journal of clinical and experimental neuropsychology.

[21]  J. Sattler Assessment of Children , 1992 .

[22]  R. Connelly,et al.  Quality of life in long-term survivors of CNS tumors of childhood and adolescence. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Edelbrock,et al.  Manual for the Child: Behavior Checklist and Revised Child Behavior Profile , 1983 .

[24]  H. Feldman,et al.  AMERICAN ACADEMY OF PEDIATRICS TECHNICAL REPORT , 2005 .

[25]  B. Moore Neurocognitive outcomes in survivors of childhood cancer. , 2005, Journal of pediatric psychology.

[26]  R. Mulhern,et al.  Neurocognitive sequelae of childhood cancers and their treatment. , 2004, Pediatric rehabilitation.

[27]  L. Hechtman,et al.  Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder , 2003 .

[28]  L. Hechtman,et al.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. , 2003, Paediatric drugs.

[29]  D. R. Smith,et al.  CHAPTER 6 – Wechsler Individual Achievement Test , 2001 .

[30]  C. Conners Conners' rating scales-revised : technical manual , 1997 .

[31]  R. Tannock,et al.  Childhood hyperactivity and psychostimulants: a review of extended treatment studies. , 1993, Journal of child and adolescent psychopharmacology.

[32]  K. Gadow Pediatric psychopharmacotherapy: a review of recent research. , 1992, Journal of child psychology and psychiatry, and allied disciplines.